Navigation Links
New DrugDev Educational Webinar Outlines Best Practices in Outsourcing Site Payments for Pharma and Biotech
Date:6/27/2017

DrugDev understands that for many sites, the top consideration for applying to a clinical study is whether they can trust the sponsor to pay them correctly and on time. As the search for high-performing sites becomes more competitive, it is vital that sponsors and CROs establish payment strategies that encourage sites to work on their studies.

At a complimentary live webinar Thursday, 29 June at 1:30pm BST/8:30am EDT global payments expert Stewart Mackie, DrugDev Vice President, Payments ROW, will offer best practices advice to pharma and biotech organizations so they can attract and keep sites interested in their studies by adopting technology-based solutions to deliver site payments accurately and on time.

Webinar: Why Outsourcing Site Payments Makes Sense
Date: 29 June 2017
Time: 1:30pm BST | 8:30am EDT
Presenter: Stewart Mackie, DrugDev Vice President, Payments ROW
Registration: Register Here
(Free for all attendees)

Attendees of this webinar will learn:

  • Positive and negative impacts of payment models on sites
  • Pros and cons of each investigator payment model in the industry
  • How an efficient payments system can make you sponsor of choice
  • Best practices from over 11 years of payments at DrugDev

DrugDev is uniquely qualified to educate pharma and biotech on the benefits of outsourcing payments. Earlier this year, DrugDev announced an industry milestone of over $2 billion in payments processed to sites worldwide on behalf of sponsors and CROs. DrugDev currently is disbursing over $40M per month to over 26,000 site recipients in 60 countries on nearly 2,000 trials. DrugDev’s payments solution is a key component of DrugDev Spark™, pharma’s unified suite of clinical operations solutions.

About the Presenter – Stew Mackie has over 20 years of experience in the pharma industry, and a wealth of expertise in the clinical trials arena. Stew leads DrugDev teams in both Operations and Finance roles. He has a particular interest in investigator payments and has spearheaded industry-leading developments in both EMEA and the APAC region.

About DrugDev
DrugDev helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14465218.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. DrugDev Signals Plans for Continued Global Expansion with Appointment of Chief Business Officer Nick Watling
2. DrugDev to Keynote Key Sessions, Reveal Unified Technology Solution Structure and Launch New Website at the Summit for Clinical Ops Executives (SCOPE)
3. DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree
4. DrugDev Hosts New Educational Webinar, “Why Doctors are Crucial to Increased Representation of Minorities in Clinical Research” April 16, with Dr. Fabian Sandoval
5. DrugDev Sponsors and Keynotes Pharma Industry Conferences as it Drives Disruption in Global Clinical Operations
6. DrugDev Founder Melissa Easy is the 2015 Partnerships in Clinical Trials Woman of the Year
7. DrugDev Hosts New Educational Webinar, “The ROI and Best Practices of Outsourcing Investigator Payments” May 14
8. DrugDev Sponsors 3rd Annual Battle of the Biotech Bands in Boston
9. DrugDev President and CEO Ibraheem Mahmood Wins PM360 ELITE Award
10. DrugDev to Speak about Site Payments and the Personal Value of Working in Clinical Research at the DIA 51st Annual Meeting
11. DrugDev Founder Melissa “Liss” Easy Named by PharmaVOICE as One of the Most 100 Inspirational People in the Pharmaceutical Industry in 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at ... , Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with website ... Awards to be consumer voted. The Magic Wand Rechargeable won in stiff competition ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical Quality ... Consulting **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , Early ... FDA scrutiny and growing demands to track and report adverse events place even ...
(Date:7/24/2017)... Island (PRWEB) , ... July 24, 2017 , ... ... a new office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The ... Jordan Fabrikant, M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. ...
(Date:7/24/2017)... ... ... “A Short Walk to the Mailbox”: a remarkable memoir of an unconventional ... Ed Clark. Ed Clark is a church music director and choral conductor. ... music and worship leader for over fifty years. He has a master’s degree ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. ... will release its second quarter 2017 operating results on ... conference call to follow at 5:00 p.m. ET. ... may listen to a live broadcast of the conference ... and referencing participant code 51641230 approximately 15 minutes prior ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
Breaking Medicine Technology: